共 10 条
- [2] A Novel Program to Accurately Quantify Infarction Volume by 99mTc MIBI SPECT, and Its Application for Re-Analyzing the Effect of Erythropoietin Administration in Patients With Acute Myocardial Infarction - A Randomized Controlled Pilot Trial of the EPO/AMI-I Study CIRCULATION JOURNAL, 2010, 74 (12) : 2741 - 2743
- [5] Design and Rationale of Low-Dose Erythropoietin in Patients with ST-Segment Elevation Myocardial Infarction (EPO-AMI-II Study): A Randomized Controlled Clinical Trial Cardiovascular Drugs and Therapy, 2012, 26 : 409 - 416
- [9] A single-center prospective randomized controlled trial evaluating the safety and efficacy of IntraCoronary Erythropoietin delivery BEfore Reperfusion: Gauging infarct size in patients with acute ST-segment elevation myocardial infarction. Study design and rationale of the 'ICEBERG Trial' CONTEMPORARY CLINICAL TRIALS, 2013, 35 (01) : 145 - 150
- [10] A phase II randomized, placebo-controlled, single-blind, multi-center dose-escalation study to evaluate tolerability, safety, pharmacokinetics, and pharimacodynamics of a single intravenous administration of INO-1001 in subjects with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention: Results of the TIMI 37A trial JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 202A - 202A